Immunocompromised travelers: Demographic characteristics, travel destinations, and pretravel health care from the u.s. global travepinet consortium

Brian S. Schwartz, Jessica Rosen, Pauline V. Han, Noreen A. Hynes, Stefan H. Hagmann, Sowmya R. Rao, Emily S. Jentes, Edward T. Ryan, Regina C. LaRocque

Research output: Contribution to journalArticlepeer-review

Abstract

An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.

Original languageEnglish (US)
Pages (from-to)1110-1116
Number of pages7
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume93
Issue number5
DOIs
StatePublished - Nov 4 2015

ASJC Scopus subject areas

  • Parasitology
  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Immunocompromised travelers: Demographic characteristics, travel destinations, and pretravel health care from the u.s. global travepinet consortium'. Together they form a unique fingerprint.

Cite this